Recombinant Erythropoietin Provides Protection against Renal Fibrosis in Adenine-Induced Chronic Kidney Disease

Chronic kidney disease (CKD) causes anemia by renal damage. In CKD, the kidney is submitted to hypoxia, persistent inflammation, leading to fibrosis and permanent loss of renal function. Human recombinant erythropoietin (rEPO) has been widely used to treat CKD-associated anemia and is known to posse...

Descripción completa

Detalles Bibliográficos
Autores principales: Vázquez-Méndez, Estefanía, Gutiérrez-Mercado, Yanet, Mendieta-Condado, Edgar, Gálvez-Gastélum, Francisco Javier, Esquivel-Solís, Hugo, Sánchez-Toscano, Yadira, Morales-Martínez, Claudia, Canales-Aguirre, Alejandro A., Márquez-Aguirre, Ana Laura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7063184/
https://www.ncbi.nlm.nih.gov/pubmed/32184703
http://dx.doi.org/10.1155/2020/8937657

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7063184/
https://www.ncbi.nlm.nih.gov/pubmed/32184703
http://dx.doi.org/10.1155/2020/8937657

Ejemplares similares